4P-Pharma at Biotech Showcase 2020

4P-Pharma’s CEO, Revital Rattenbach, will attend the upcoming Biotech Showcase 2020 in San Francisco (USA), January 13th-15th, 2020.

Contact us via the partnering platform or by e-mail to schedule a meeting and discuss future collaborations.

4P-Pharma will attend the 10th DDIP, November 28th-29th 2019 – Barcelona, Spain

We’re glad to announce that Céline Martin, 4P-Pharma’s R&D Manager will speak during  the 10th Drug Discovery Innovation Programme (10th DDIP) organized by the World BI, November 28th-29th 2019, at Barcelona, Spain: “Pharmaceutical Development Through A Rapid Value Creation Business Model”.

To learn more about 4P-Pharma, our pipeline and our partnerships, please feel free to contact Céline or Roselina Lam, our Business Developer, via email.

4P-Pharma presents 4P-004 data at the ACR/ARP Annual Meeting in Atlanta

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” (#1973) will be presented during the ACR/ARP Annual Meeting in Atlanta, Georgia November 8 – 13, 2019, by Pr. Francis Berenbaum (Professor of Rheumatology at Sorbonne University, in Paris (France)).

For further information, please click on the following link:


4P-Pharma at Meet2Win 2017

4P Pharma’s CEO, Revital Rattenbach, and our business developer Luigi Formicola, will be attending the upcoming MEET2WIN Oncology Business convention in Bordeaux, May 11-12th 2017.

4P-Pharma develops innovative drugs notably in the oncology field. We partner with academic institutions, TTOs, and biotech/pharma companies, our adaptative collaborative on a co-share co-risk model.

Contact us via the partnering platform to schedule a meeting and discuss collaboration opportunities.